Colgate Palmolive (India) Limited — Q4 FY25
Colgate-Palmolive India reported Q4 FY25 revenue of INR 1,452 crore, a -1.9% decline YoY, with flat volumes and negative pricing due to elevated trade promotions.
Financial stats pending filing verification
Did management answer the analysts?
Every material analyst question, graded on whether management actually answered it — with the verbatim exchange and quantitative claims checked against filed numbers.
How did Colgate become market leader in sensitive segment? Is it sustainable?
Asked by Abnish
Management did not directly confirm how leadership was achieved or sustainability, instead pivoted to broader therapeutic strategy.
Read the exchange
We have seen another company, another brand being the leader for many years. You said that you have become the market leader here. If you could tell us, was there some promotion-led intensity which has helped? Is this sustainable?
My comment was really in the space of there is, given that the oral health of this country is a little bit challenged, there is opportunity for us to build a therapeutic segment... Our focus in this area is actually to drive gum health...
When will promotional intensity normalize? Who will blink first?
Asked by Abnish
Management acknowledged the question but gave no specific timeframe or conditions for normalization.
Read the exchange
Competitive intensity in toothpaste seems very high... When does the promotional intensity coming back to the normal levels?
We did up our promotional spending during the last FY... We believe temporarily there could be a bit of up and down, but in the longer run, this would be about the brand...
How to measure success of oral health campaign given muted numbers?
Asked by Abnish
Management provided engagement metrics but did not connect to financial performance or give a clear ROI framework.
Read the exchange
Given the numbers are muted, how do we measure that it has worked? Because you have done this earlier many years, but this time the dentist connect and QR code, all those were there. As an analyst, how do we judge it has worked?
I think you need to take a look at what is the intent of a company... I would judge the way I judge the success of this activity... is for us to see what's the level of traction that we're getting from consumers... Four and a half million is the number.
Is the mass end (Colgate Strong Teeth) where competition is hurting?
Asked by Amit Sachdeva, UBS
Management confirmed the analyst's inference and provided a clear breakdown of urban segments.
Read the exchange
When you allude to competition, can I sort of infer from it that the mass end or Colgate Strong Teeth variant is where you see significant decline actually in the portfolio? That is where the competition concern is coming from.
I think you're absolutely right... Where the problem actually sits in the last little while... has been the bottom 70% of urban India. We are seeing that they are under pressure...
Is competition receding or intensifying? Outlook for margins?
Asked by Amit Sachdeva, UBS
Management discussed competitive intensity but did not give a clear timeline for easing or specific margin guidance.
Read the exchange
How do we sort of relate it back to the competition comment that you made that competition has also impacted performance this quarter? ... And relating back to what should be the outlook for, say, next two quarters? ... especially related back to margins as well.
I think firstly, if I take a look at our comment on competitive intensity, I think it links to the comments that Jacob was making in terms of how much money competition is spending largely driven by trade...
Is trade investment specific to QuickCommerce or general trade?
Asked by Amit Sachdeva, UBS
Management clearly stated that trade investment is primarily in general trade, not QuickCommerce.
Read the exchange
Since you mentioned that competitive spends and the trade, is it specific to a particular channel like QuickCommerce or something, or is it pervasive across DT as well?
I think to the first question on where is the trade investment going, actually, the trade investment is going more in general trade. General trade continues to be about three-quarters of this market.
Outlook for gross and EBITDA margins for FY2026?
Asked by Arnav Mitra, Goldman Sachs
Management explicitly declined to provide margin guidance for FY2026.
Read the exchange
What is the outlook for gross and EBITDA margins for FY2026? Do you benefit from lower input costs, or will the high competitive intensity lead to some headwinds?
We are not targeting any particular level of gross margin or EBITDA increase. It will be a result of doing all the right things. I would not give a guidance on any particular level at this point.
How are you managing channel conflicts between GT and emerging channels?
Asked by Jay Doshi, Kotak
Management explained specific actions to manage channel conflicts, including pricing parity and premium portfolio allocation.
Read the exchange
We have witnessed significant discounts on MT or e-commerce platforms. How are you managing channel conflicts between GT and emerging channels?
Firstly, to ensure that there is a degree of parity pricing across all of the channels because it is important for us that all of the channels grow...
What was premiumization contribution to value growth in FY2025?
Asked by Jay Doshi, Kotak
Management did not disclose the actual contribution percentage but provided growth expectations.
Read the exchange
What was the contribution of premiumization mix to value growth in FY2025? What could be the contribution of premiumization of your revenue, Keka, over the next two to three years?
We tend not to comment on the share of premiumization, but more what we expect that premium would grow at... premium should be at least 2x faster... now... 4x...
Why was pricing mix growth missing despite premiumization focus?
Asked by Priyank Chheda, Vallum Capital
Management explained the reason but did not quantify the expected mix improvement or price growth.
Read the exchange
Pricing mix growth for FY2025 was missing despite premiumization focus for full year. What is the mix improvement on total price growth expected ahead?
On price growth, as we mentioned, we've been investing in trade over the last year or so. That has impacted the pricing growth. Going forward... we do expect going forward, pricing will be a component of the sales growth.
What was volume growth for the recent quarter?
Management clearly stated volume was flat and pricing slightly negative.
Read the exchange
The question is to understand volume growth for recent quarter.
In terms of volume growth, as we mentioned, our pricing did not contribute to it. We actually had slightly negative pricing. Volume was flat in the last quarter.
Is lower urban demand due to down-trading from premium to mass?
Asked by Disha Sheth, Anvil
Management clearly denied down-trading and explained volume decline is due to usage titration.
Read the exchange
When on the press release, you mentioned that there's lower urban demand. Does that mean that the customers have down-traded themselves from a Colgate Total to a normal Colgate? Has that impacted our sales?
I think we're not actually seeing down-trading in the market. The reason for the slowing volume growth... is actually consumers titrate the amount of toothpaste that they use.